Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1983 1
1987 2
1988 2
1989 1
1991 2
1995 1
2002 1
2003 2
2004 2
2005 5
2006 2
2007 8
2008 7
2009 6
2010 8
2011 11
2012 6
2013 6
2014 11
2015 16
2016 10
2017 14
2018 8
2019 8
2020 12
2021 11
2022 14
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study.
Wong A, Brunetta J, De Wet J, Logue K, Loemba H, Saifi T, Mumm D, Marongiu A, Harrison R, Thorpe D, Trottier B. Wong A, et al. Among authors: trottier b. Medicine (Baltimore). 2024 Apr 19;103(16):e37785. doi: 10.1097/MD.0000000000037785. Medicine (Baltimore). 2024. PMID: 38640301 Free PMC article.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
IL-32 Drives the Differentiation of Cardiotropic CD4+ T-Cells Carrying HIV DNA in People Living with HIV.
Ramani H, Gosselin A, Bunet R, Jenabian MA, Sylla M, Pagliuzza A, Chartrand-Lefebvre C, Routy JP, Goulet JP, Thomas R, Trottier B, Martel-Laferrière V, Fortin C, Chomont N, Fromentin R, Landay A, Durand M, Ancuta P, El-Far M, Tremblay C. Ramani H, et al. Among authors: trottier b. J Infect Dis. 2023 Dec 19:jiad576. doi: 10.1093/infdis/jiad576. Online ahead of print. J Infect Dis. 2023. PMID: 38113908
Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
Doyle CM, Milwid RM, Cox J, Xia Y, Lambert G, Tremblay C, Otis J, Boily MC, Baril JG, Thomas R, Blais AD, Trottier B, Grace D, Moore DM, Mishra S, Maheu-Giroux M. Doyle CM, et al. Among authors: trottier b. J Int AIDS Soc. 2023 Dec;26(12):e26194. doi: 10.1002/jia2.26194. J Int AIDS Soc. 2023. PMID: 38054579 Free PMC article.
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.
Benlarbi M, Richard J, Bourassa C, Tolbert WD, Chartrand-Lefebvre C, Gendron-Lepage G, Sylla M, El-Far M, Messier-Peet M, Guertin C, Turcotte I, Fromentin R, Verly MM, Prévost J, Clark A, Mothes W, Kaufmann DE, Maldarelli F, Chomont N, Bégin P, Tremblay C, Baril JG, Trottier B, Trottier S, Duerr R, Pazgier M, Durand M, Finzi A. Benlarbi M, et al. Among authors: trottier b. J Infect Dis. 2024 Mar 14;229(3):763-774. doi: 10.1093/infdis/jiad503. J Infect Dis. 2024. PMID: 38035854 Free PMC article.
Baseline characteristics of a prospective cohort study of aging and cardiovascular diseases among people living with HIV.
Giguère K, Chartrand-Lefebvre C, Baril JG, Conway B, El-Far M, Falutz J, Harris M, Jenabian MA, Leipsic J, Loutfy M, Mansour S, MacPherson P, Margolese S, McMillan JM, Monteith K, Murray MCM, Pick N, Thomas R, Trottier B, Trottier S, Tsoukas C, Walmsley S, Wong A, Tremblay C, Durand M; Canadian HIV And Aging Cohort Study Group. Giguère K, et al. Among authors: trottier b. HIV Med. 2023 Dec;24(12):1210-1221. doi: 10.1111/hiv.13550. Epub 2023 Oct 1. HIV Med. 2023. PMID: 37779267
Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia.
Benlarbi M, Richard J, Bourassa C, Tolbert WD, Chartrand-Lefebvre C, Gendron-Lepage G, Sylla M, El-Far M, Messier-Peet M, Guertin C, Turcotte I, Fromentin R, Verly MM, Prévost J, Clark A, Mothes W, Kaufmann DE, Maldarelli F, Chomont N, Bégin P, Tremblay C, Baril JG, Trottier B, Trottier S, Duerr R, Pazgier M, Durand M, Finzi A; Canadian HIV; Aging Cohort Study. Benlarbi M, et al. Among authors: trottier b. medRxiv [Preprint]. 2023 Aug 16:2023.08.15.23294128. doi: 10.1101/2023.08.15.23294128. medRxiv. 2023. PMID: 37645879 Free PMC article. Updated. Preprint.
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM; GS-US-200-4625 investigators. Ogbuagu O, et al. Among authors: trottier b. Lancet HIV. 2023 Aug;10(8):e497-e505. doi: 10.1016/S2352-3018(23)00113-3. Epub 2023 Jul 11. Lancet HIV. 2023. PMID: 37451297 Clinical Trial.
Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis.
Bunet R, Roy-Cardinal MH, Ramani H, Cleret-Buhot A, Durand M, Chartrand-Lefebvre C, Routy JP, Thomas R, Trottier B, Ancuta P, Hanna DB, Landay AL, Cloutier G, Tremblay CL, El-Far M. Bunet R, et al. Among authors: trottier b. Viruses. 2023 Mar 8;15(3):700. doi: 10.3390/v15030700. Viruses. 2023. PMID: 36992409 Free PMC article.
177 results